20 mg/30 mg
INDICATION: Oral vinorelbine is indicated as a single agent and in combination chemotherapy in the treatment of non-small cell lung cancer and metastatic breast cancer.
GENERIC NAME: Vinorelbine
DOSAGE STRENGTH/FORM: The recommended regimen is: First three administrations: 60 mg/m² of body surface area, administered once weekly. Subsequent administrations: Beyond the third administration, it is recommended to increase the dose of vinorelbine to 80 mg/m² once weekly except in those patients for whom the neutrophil count dropped once below 500/mm3 or more than once between 500 and 1000/mm3 during the first three administrations at 60 mg/m2.
PRESENTATION: Each Soft-Gelatin Capsule contains: Vinorelbine tartrate 27.70 mg equivalent to Vinorelbine 20 mg Vinorelbine tartrate 41.55 mg equivalent to Vinorelbine 30 mg
MANUFACTURER: Pierre Fabre Médicament Production Aquitaine Pharm International 1 Avenue du Béarn - 64320 Idron - France